Filgrastim‐induced stem cell mobilization in chronic myeloid leukaemia patients during imatinib therapy: safety, feasibility and evidence for an efficient in vivo purging [PDF]
Karl‐Anton Kreuzer+5 more
openalex +1 more source
Pharmacokinomic Profiling Using Patient-Derived Cell Lines Predicts Sensitivity to Imatinib in Dermatofibrosarcoma Protuberans. [PDF]
Noguchi R+6 more
europepmc +1 more source
Further Insight Found into Molecular Basis for Imatinib Resistance in CML
Peggy Peck
openalex +1 more source
Chronic Myeloid Leukemia Following Therapy With Imatinib Mesylate (Gleevec): Bone Marrow Histopathology and Correlation With Genetic Status [PDF]
Debra Resta+7 more
openalex +1 more source
Imatinib Desensitization After a Type IV Hypersensitivity Reaction in a Gastrointestinal Stromal Tumor Patient-A Case Report. [PDF]
van der Kleij MBA+10 more
europepmc +1 more source
Imatinib Superior to Standard Therapy in Newly Diagnosed CML
Lilian Delmonte
openalex +1 more source
Imatinib or transplant for chronic myeloid leukaemia? [PDF]
Charles Craddock+2 more
openalex +1 more source
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study. [PDF]
Rothman AMK+15 more
europepmc +1 more source
A CASE OF GIST SUCCESSFULLY TREATED WITH IMATINIB MESILATE(STI571).
T. Terada+5 more
openalex +2 more sources
High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome–positive chronic phase chronic myeloid leukemia [PDF]
Hagop M. Kantarjian+12 more
openalex +1 more source